Start Date
December 31, 2021
Primary Completion Date
October 31, 2022
Study Completion Date
January 31, 2023
Netarsudil 0.02% QD
This is a randomized, single-center, investigator-masked, 2-period, 8-week treatment study with washout and crossover between treatment periods. There will be 2 treatments in this study: netarsudil 0.02% QD and timolol maleate 0.5% BID.
Timolol maleate 0.5% BID
This is a randomized, single-center, investigator-masked, 2-period, 8-week treatment study with washout and crossover between treatment periods. There will be 2 treatments in this study: netarsudil 0.02% QD and timolol maleate 0.5% BID.
Collaborators (1)
Aerie Pharmaceuticals
INDUSTRY
University of California, San Diego
OTHER